Candidate tumor suppressor RIZ is frequently involved in colorectal carcinogenesis.
The distal portion of chromosome 1p is one of the most commonly affected regions in human cancer. In this study of hereditary and sporadic colorectal cancer, a region of frequent deletion was identified at 32.2 centimorgans from 1ptel. Deletion breakpoints clustered in the vicinity of or inside the gene RIZ, which encodes a retinoblastoma protein-interacting zinc finger protein. Sequence analysis revealed frequent frameshift mutations of the RIZ gene. The mutations consisted of 1- or 2-bp deletions of a coding (A)(8) or (A)(9) tract and were confined to microsatellite-unstable colorectal tumors, being present in 9 of 24 (37.5%) primary tumors and in 6 of 11 (54.5%) cell lines; in 2 cell lines the mutation was homozygous/hemizygous. The mutations apparently were selected clonally in tumorigenesis, because similar poly(A) tracts in other genes were not affected. Two alternative products of the gene exist, RIZ1, which contains a PR (PRDI-BF1-RIZ1) domain implicated in tumor suppressor function, and RIZ2, which is lacking this motif. Furthermore, the C-terminal region, which contains the poly(A) tracts, includes a PR-binding motif, possibly mediating interactions with other proteins or with RIZ itself (oligomerization). Four of eleven microsatellite-unstable colorectal cancer cell lines, three of which had frameshifts, showed reduced or absent mRNA expression of RIZ1. In a cell line that is homozygous/hemizygous for the typical frameshift mutation, immunoblotting showed truncated RIZ protein, whereas adenovirus-mediated RIZ1 expression caused G(2)/M arrest and apoptosis. We propose that RIZ is a target of the observed 1p alterations, with impairment of the PR domain-mediated function through either frameshift mutation or genomic deletion.
Chadwick
R B
RB
Division of Human Cancer Genetics and Department of Pathology, Ohio State University, Comprehensive Cancer Center, Columbus, OH 43210, USA.
Jiang
G L
GL
Bennington
G A
GA
Yuan
B
B
Johnson
C K
CK
Stevens
M W
MW
Niemann
T H
TH
Peltomaki
P
P
Huang
S
S
de la Chapelle
A
A
D017209:Apoptosis; D002872:Chromosome Deletion; D002878:Chromosomes, Human, Pair 1; D015179:Colorectal Neoplasms / Q000235:genetics*; D004252:DNA Mutational Analysis; D004268:DNA-Binding Proteins; D016368:Frameshift Mutation; D016195:G2 Phase; D016147:Genes, Tumor Suppressor; D011495:Histone-Lysine N-Methyltransferase; D006801:Humans; D019656:Loss of Heterozygosity; D008938:Mitosis; D009687:Nuclear Proteins / Q000235:genetics*; D011061:Poly A / Q000235:genetics; D020033:Protein Isoforms; D016160:Retinoblastoma Protein / Q000378:metabolism; D014157:Transcription Factors; D014407:Tumor Cells, Cultured
D004268:DNA-Binding Proteins; D009687:Nuclear Proteins; D020033:Protein Isoforms; D016160:Retinoblastoma Protein; D014157:Transcription Factors; D011061:Poly A; D011495:Histone-Lysine N-Methyltransferase; C093563:PRDM2 protein, human